Single-Dose Ad26.COV2.S Effective Against COVID-19

FRIDAY, April 23, 2021 -- A single dose of human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 spike protein (Ad26.COV2.S) protects against moderate- to severe-critical and severe-critical COVID-19,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news